BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1107252)

  • 1. [Basis of immunosuppressive effect of D-penecillamine].
    Schumacher K
    Internist (Berl); 1975 Oct; 16(10):460-5. PubMed ID: 1107252
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacology of immunosuppressive agents].
    Genazzani E; Periti P
    Minerva Med; 1978 Aug; 69(38):2587-604. PubMed ID: 714259
    [No Abstract]   [Full Text] [Related]  

  • 3. Some immunological effects of penicillamine.
    Chen DM; Di Sabato G; Field L; Gallo AA; Harshman S
    Clin Exp Immunol; 1977 Nov; 30(2):317-22. PubMed ID: 304785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppression: bioligical bases and usage].
    Wilmanns W
    Internist (Berl); 1975 Oct; 16(10):451-9. PubMed ID: 1107251
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic principles of immunopharmacology].
    Floersheim GL
    Clin Ter; 1981 Jan; 96(1):3-10. PubMed ID: 7237947
    [No Abstract]   [Full Text] [Related]  

  • 6. Anesthesia and immunology.
    Duncan PG; Cullen BF
    Anesthesiology; 1976 Nov; 45(5):522-38. PubMed ID: 1086067
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacology of chemical immunosuppression].
    Potel J; Brock N
    Verh Dtsch Ges Rheumatol; 1972; 2():Suppl 2:339-57. PubMed ID: 5051958
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes.
    Lipsky PE
    J Clin Invest; 1984 Jan; 73(1):53-65. PubMed ID: 6606652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of the effect of immunosuppression on leukocyte migration inhibition in various autoimmune diseases in children].
    Lukas A; Cesarz E; Sliwa F; Lukas W; Sychłowy A
    Pediatr Pol; 1978 Nov; 53(11):1271-5. PubMed ID: 309586
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressive effect of D-penicillamine].
    Junge U; Hauswaldt C; Perings E
    Verh Dtsch Ges Inn Med; 1973; 79():616-8. PubMed ID: 4790310
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological effects of diethylstilbestrol and estramustine phosphate.
    Haukaas SA
    Scand J Urol Nephrol Suppl; 1984; 83():1-32. PubMed ID: 6387896
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of D-penicillamine on inflammatory and immune reactions.
    Harth M; Keown PA; Orange JF
    Clin Invest Med; 1984; 7(1):45-51. PubMed ID: 6723124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short introduction to some current problems in immunosuppression and immunostimulation].
    Gross R
    Internist (Berl); 1975 Oct; 16(10):449-50. PubMed ID: 1107250
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of immunosuppression on the development of immunity to fowl typhoid.
    Cameron CM; Brett OL; Fuls WJ
    Onderstepoort J Vet Res; 1974 Mar; 41(1):15-21. PubMed ID: 4213431
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of L-asparaginase on cellular and humoral immunity].
    Astaldi G; Migu D
    Stud Cercet Med Interna; 1972; 13(4):301-15. PubMed ID: 4566265
    [No Abstract]   [Full Text] [Related]  

  • 16. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
    Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
    [No Abstract]   [Full Text] [Related]  

  • 17. Suggested mode of action of D-penicillamine as an immunosuppressive agent in rheumatoid arthritis.
    Lipsky PE
    Z Rheumatol; 1988; 47 Suppl 1():6-8. PubMed ID: 2975107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Theoretical basis of immunosuppression in autoimmune diseases].
    Haustein UF
    Dermatol Monatsschr; 1972 Aug; 158(8):547-71. PubMed ID: 4404036
    [No Abstract]   [Full Text] [Related]  

  • 19. Malononitrilamides inhibit T- and B-cell responsiveness.
    Kurrle R; Bartlett R; Ruuth E; Lauffer L; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3053-6. PubMed ID: 8962184
    [No Abstract]   [Full Text] [Related]  

  • 20. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies.
    Franchimont D
    Ann N Y Acad Sci; 2004 Jun; 1024():124-37. PubMed ID: 15265777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.